FOLLICULAR LYMPHOMA ( FL)
Clinical trials for FOLLICULAR LYMPHOMA ( FL) explained in plain language.
Never miss a new study
Get alerted when new FOLLICULAR LYMPHOMA ( FL) trials appear
Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA ( FL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
CAR-T therapy shows promise in Long-Term Follow-Up for blood cancers
Disease control CompletedThis study followed 16 patients with various B-cell cancers (like lymphoma and leukemia) who had already received CLBR001 CAR-T cells. The goal was to check for long-term side effects and see how well the treatment controlled the disease over time. Researchers monitored new or la…
Matched conditions: FOLLICULAR LYMPHOMA ( FL)
Phase: PHASE1 • Sponsor: Calibr, a division of Scripps Research • Aim: Disease control
Last updated May 26, 2026 11:18 UTC
-
Drug access bridge: tazemetostat rollover study offers continued treatment
Disease control CompletedThis study allowed people with certain cancers who had already benefited from the drug tazemetostat in earlier studies to keep receiving it. The main goal was to track long-term safety and side effects. Participants had already shown clinical benefit and continued treatment under…
Matched conditions: FOLLICULAR LYMPHOMA ( FL)
Phase: PHASE1, PHASE2 • Sponsor: Epizyme, Inc. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New drug combo shows promise for Hard-to-Treat blood cancers
Disease control CompletedThis study tested a combination of two drugs, acalabrutinib and pembrolizumab, in 161 people with different types of blood cancers like lymphoma and leukemia. The main goal was to check safety and see how well the drugs worked together. Researchers measured side effects and tumor…
Matched conditions: FOLLICULAR LYMPHOMA ( FL)
Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated May 22, 2026 13:53 UTC